Enzo Biochem, Inc. (NYSE:ENZ) announced today the company was added to
the Russell 2000® and Russell 3000® Indexes following the reconstitution
of Russell Investment Group's family of US indexes after the market
closed on June 27, 2014.
Russell determines membership for its equity indexes primarily by
objective, market-capitalization rankings and style attributes. Russell
Indexes are widely used by investment managers and institutional
investors for index funds and as benchmarks for both active and passive
investment strategies. As of March 31, 2014, Russell had more than $259
billion in assets under management and works with over 2,500
institutional clients, independent distribution partners and individual
investors globally. Approximately $5.2 trillion in assets are
benchmarked to the Russell Indexes.
About Russell 2000 Index
Measures the performance of the small-cap segment of the U.S. equity
market. The Russell 2000 Index is a subset of the Russell 3000 Index and
represents approximately 10% of the total market capitalization of the
Russell 3000. It includes approximately 2000 small-cap companies based
on a combination of their market cap and current index membership. The
Russell 2000 is constructed to provide a comprehensive and unbiased
small-cap barometer and is completely reconstituted annually to ensure
larger stocks do not distort the performance and characteristics of the
true small-cap opportunity set. The Russell 2000® Index measures the
performance of the small-cap segment of the U.S. equity market and is a
subset of the Russell 3000® representing approximately 10 percent of the
total market capitalization of that index. Membership in the Russell
2000® Index includes automatic inclusion in the appropriate growth and
style indexes.
About Russell 3000 Index
Measures the performance of the largest 3,000 U.S. companies
representing approximately 98% of the investable U.S. equity market. The
Russell 3000 Index is constructed to provide a comprehensive, unbiased
and stable barometer of the broad market and is completely reconstituted
annually to ensure new and growing equities are reflected. The Russell
1000, which measures the performance of the large-cap segment of the
U.S. equity universe, and Russell 2000 are subsets of the Russell 3000.
About Enzo Biochem
Enzo Biochem is a pioneer in molecular diagnostics, leading the
convergence of clinical laboratories, life sciences and therapeutics
through the development of unique diagnostic platform technologies that
provide numerous advantages over previous standards. A global company,
Enzo Biochem utilizes cross-functional teams to develop and deploy
products systems and services that meet the ever-changing and rapidly
growing needs of health care both today and into the future.
Underpinning Enzo Biochem's products and technologies is a broad and
deep intellectual property portfolio, with patent coverage across a
number of key enabling technologies.
Except for historical information, the matters discussed in this news
release may be considered forward-looking" statements within the meaning
of Section 27A of the Securities Act of 1933, as amended and Section 21E
of the Securities Exchange Act of 1934, as amended Such statements
include declarations regarding the intent, belief or current
expectations of the Company and its management, including those related
to cash flow, gross margins, revenues, and expenses are dependent on a
number of factors outside of the control of the company including, inter
alia, the markets for the Company's products and services, costs of
goods and services, other expenses, government regulations, litigations,
and general business conditions. See Risk Factors in the Company's Form
10-K for the fiscal year ended July 31, 2013. Investors are cautioned
that any such forward-looking statements are not guarantees of future
performance and involve a number of risks and uncertainties that could
materially affect actual results. The Company disclaims any obligations
to update any forward-looking statement as a result of developments
occurring after the date of this press release.
Copyright Business Wire 2014